The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
about
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewInnate and adaptive immunity in immune thrombocytopeniaFrequently asked questions on seven rare adverse events following immunization.Safety of human papillomavirus vaccines: a review.Vaccine administration and the development of immune thrombocytopenic purpura in childrenNewly diagnosed immune thrombocytopenia: update on diagnosis and management.Clinical practice: immune thrombocytopenia in paediatrics.Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines.Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.Quantification of specific T and B cells immunological markers in children with chronic and transient ITP.Physicians' confidence in vaccine safety studiesA vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.Public health: An injection of trust.Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.Methodology for computing the burden of disease of adverse events following immunization.Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre
P2860
Q26700078-0E4DAD36-823F-4304-8EE5-23B1D4A68B4AQ26859642-0AB4928D-C681-4649-98B5-FB8F91E9B982Q30234430-7EE6BFB1-DFEE-4148-B689-C2D240AD60EAQ33162724-A8DFCB32-A474-412D-AB42-A03E3390E7F3Q33405328-4E7261D9-22DB-42C7-A5DC-4C43700A516FQ33410716-3A83BE1F-1186-44EC-8A2C-34BDC2380DD0Q33412475-5FD1F695-5E6D-45A0-96F7-B72168D5CEC7Q33414858-21BADDF4-01AE-4E36-B391-DDF5633F593FQ33418883-CE50D1C2-DA2B-4846-BD62-6126571DC2BDQ33424247-AD200D25-8BF5-4986-9679-B7DC244F83A8Q33442120-6249D0D5-FE54-4D57-A2A9-FE4AB4B5B241Q36175636-67459C62-3D9D-45A7-A844-01F7A7CAA6F7Q39029570-A008CD48-9498-451A-B853-7E2363EDEDAEQ39350135-2545B1F5-564D-4904-9255-445A14688BC6Q40435214-83FF6E91-C992-463C-91DC-4BC330D2B034Q42224918-83779D87-C36F-4328-A574-A200F2BF4928Q44475855-6BAD4FA3-8B2F-4B23-8A48-F904AFD2C958Q51556405-481582E8-8E16-47D7-BD78-9224BACCF632Q57822987-1FFC1E8A-55B6-401B-8C52-495A627CF47C
P2860
The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The risk of immune thrombocyto ...... n in children and adolescents.
@ast
The risk of immune thrombocyto ...... n in children and adolescents.
@en
type
label
The risk of immune thrombocyto ...... n in children and adolescents.
@ast
The risk of immune thrombocyto ...... n in children and adolescents.
@en
prefLabel
The risk of immune thrombocyto ...... n in children and adolescents.
@ast
The risk of immune thrombocyto ...... n in children and adolescents.
@en
P2093
P356
P1433
P1476
The risk of immune thrombocyto ...... n in children and adolescents.
@en
P2093
Aysha Akhtar
Cynthia Nakasato
David L McClure
Hector S Izurieta
Jason M Glanz
Matthew F Daley
Robert Ball
Robert L Davis
Roger Baxter
Sean T O'Leary
P304
P356
10.1542/PEDS.2011-1111
P407
P577
2012-01-09T00:00:00Z